Work is in progress to define a clinical rating scale for (semi-)quantitative characterization of camptocormia. After creating a pre-version and its evaluation on a local stage, we aim to refine and establish it with help from our international colleagues and the Movement Disorder Society. The assessment of the severity of camptocormia might be a relevant outcome parameter for therapeutic studies to come.